Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (Studies Of Left Ventricular Dysfunction)

American Journal of Cardiology

Volumn 84, Issue 3, 1999, Pages 299-303

  Rashid, Haroon ^a,c   Exner, Derek V ^a   Mirsky, Israel ^a   Cooper, Howard A ^a,c   Waclawiw, Myron A ^b   Domanski, Michael J ^a  

^a Clinical Trials Research Group   (United States)

^b Office of Biostatistics Research   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SCINTIANGIOGRAPHY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIONUCLIDE VENTRICULOGRAPHY; RETROSPECTIVE STUDIES; RISK; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033180431     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00280-5     Document Type: Article

References (24)

1. Risk stratification and survival after myocardial infarction. N Engl J Med. 309:1983;331-336.
2. Gradman A., Deedwania P., Cody R., Massie B., Packer M., Pitt B., Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. J Am Coll Cardiol. 14:1989;564-570.
3. Zaret B.L., Wackers F.J., Terrin M.L., Forman S.A., Williams D.O., Knatterud G.L., Braunwald E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction results of Thromobolysis in Myocardial Infarction (TIMI) phase II study . J Am Coll Cardiol. 26:1995;73-79.
4. Jensen-Urstad K., Bouvier F., Hojer J., Ruiz H., Hulting J., Samad B., Thorstrand C., Jensen-Urstad M. Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. Am J Cardiol. 81:1998;538-544.
5. Cohn J.N., Archibald D.G., Ziesche S., Franciosa J.A., Harston W.E., Tristani F.E., Dunkman W.B., Jacobs W., Francis G.S., Flohr K.H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 314:1986;1547-1552.
6. Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W.B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
7. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J. Jr, Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 327:1992;669-677.
8. Køber L., Torp-Pedersen C., Carlsen J.E., Bagger H., Eliasen P., Lyngborg K., Videbaek J., Cole D.S., Auclert L., Pauly N.C. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction.Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 333:1995;1670-1676.
9. Waldo A.L., Camm A.J., deRuyter H., Freidman P.L., MacNeil D.J., Pitt B., Pratt M., Rodda B.E., Schwartz P.J. Survival with oral d-sotalol in patients with left ventricular dysfunction after myocardial infarction rationale, design, and methods (the SWORD trial) . Am J Cardiol. 75:1995;1023-1027.
10. Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction rationale, design, and patient characteristics of the DIAMOND studies . Clin Cardiol. 20:1997;704-710.
11. Studies of Left Ventricular Dysfunction (SOLVD) - Rationale, design and methods two trials that evaluate the effect of enalapril in patients with reduced ejection fraction . Am J Cardiol. 66:1990;315-322.
12. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
13. Effects of enalapril on mortality and development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
14. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 2:1989;358-367.
15. van Royen N., Jaffe C.C., Krumholz H.M., Johnson K.M., Lynch P.J., Natale D., Atkinson P., Deman P., Wackers F.J. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol. 77:1996;843-850.
16. Chalmers T.C., Celano P., Sacks H.S., Smith H. Jr. Bias in treatment assignment in controlled clinical trials. N Engl J Med. 309:1983;1358-1361.
17. Cohn P.F., Gorlin R., Collins J.J., Cohn L. The left ventricular ejection fraction as prognostic guide in the surgical treatment of coronary heart disease and valvular heart disease. Am J Cardiol. 34:1974;135-141.
18. Ray S.G., Metcalfe M.J., Oldroyd K.G., Pye M., Martin W., Christie J., Dargie H.J., Cobbe S.M. Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction? Br Heart J. 73:1995;466-469.
19. Naik M.M., Diamond G.A., Pai T., Soffer A., Siegel R.J. Correspondence of left ventricular ejection fraction determinations from two-dimensional echocardiography, radionuclide angiography and contrast cineangiography. J Am Coll Cardiol. 25:1995;937-942.
20. Barbir M., Lazem F., Banner N., Mitchell A., Yacoub M. The prognostic significance of non-invasive cardiac tests in heart transplant recipients. Eur Heart J. 18:1997;692-696.
21. Urena P.E., Lamas G.A., Mitchell G., Flaker G.C., Smith S.C. Jr, Wackers F.J., McEwan P., Pfeffer M.A. Ejection fraction by radionuclide ventriculography and contrast left ventriculogram. A tale of two techniques. SAVE Investigators. Survival and Ventricular Enlargement. J Am Coll Cardiol. 33:1999;180-185.
22. Khanal S., Daggubati R., Gaalla A., Shah P.M., Pai R.G. Left ventricular cavity obliteration during dobutamine stress echocardiography is associated with female sex and left ventricular size and function. J Am Soc Echocardiogr. 11:1998;957-960.
23. Kornbluth M., Liang D.H., Paloma A., Schnittger I. Native tissue harmonic imaging improves endocardial border definition and visualization of cardiac structures. J Am Soc Echocardiogr. 11:1998;693-701.
24. Schneider RM, Jaszczak RJ, Coleman RE, Cobb FR. Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes. J Nucl Med 1984 Jul;25:747-754.